Hormone replacement and menopausal symptoms following hysterectomy

American Journal of Epidemiology

Volumn 146, Issue 10, 1997, Pages 870-880

  Langenberg, Patricia ^a   Kjerulff, Kristen H ^a   Stolley, Paul D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen replacement therapy; Hormones; Hysterectomy; Menopause; Ovariectomy

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY; OVARIECTOMY; POSTMENOPAUSE; PREMENOPAUSE; RACE DIFFERENCE; SYMPTOMATOLOGY;

EID: 0030665145     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009204     Document Type: Article

References (62)

1. Wilcox LS, Koonin LM, Pokras R, et al. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994;83:549-55.
2. Pokras R, Hufnagel VG. Hysterectomy in the United States, 1965-84. Am J Public Health 1988;78:852-3.
3. Wise PM, Krajnak KM, Kashon ML. Menopause: the aging of multiple pacemakers. Science 1996;273:67-70.
4. Parker M, Bosscher J, Barnhill D, et al. Ovarian management during radical hysterectomy in the premenopausal patient. Obstet Gynecol 1993;82:187-90.
5. Menon RK, Okonofua FE, Agnew JE, et al. Endocrine and metabolic effects of simple hysterectomy. Int J Gynaecol Obstet 1987;25:459-63.
6. de Neef JC, Hollenbeck ZJ. The fate of ovaries preserved at the time of hysterectomy. Am J Obstet Gynecol 1966;96: 1088-97.
7. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987:47:94-100.
8. Weinstein L. Hormonal therapy in the patient with surgical menopause. Obstet Gynecol 1990;75:47S-50S.
9. Stampfer MJ, Willett WC, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985;313:1044-9.
10. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
11. Ettinger B, Friedman GD, Bush T, et al. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6-12.
12. Lobo RA. Benefits and risks of estrogen replacement therapy. Am J Obstet Gynecol 1995:173:982-9.
13. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75-8.
14. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/ Progestin Interventions (PEPI) Trial. JAMA 1995:273:199-208.
15. Kirn CJ, Jang HC, Cho DH, et al. Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. Arterioscler Thromb 1994:14:275-81.
16. Haenggi W, Birkhaeuser MH. A new peroral estrogen/ progestin combination for postmenopausal hormonal substitution: an open multicentric field study. Maturitas 1993; 16:111-22.
17. van der Mooren MJ, Leuven JA, Rolland R. Effect of conjugated estrogens with and without medrogestone: a prospective study. Maturitas 1994; 19:33-42.
18. Granfone A, Campos H, McNamara JR, et al. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Metabolism 1992:41:1193-8.
19. Watts NB, Notelovitz M, Timmons MC, et al. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995:85:529-37.
20. Espeland MA, Applegate W, Furberg CD, et al. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. Am J Epidemiol 1995;142:1011-19.
21. The Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1996:276:1389-96.
22. Heiss CJ, Sanborn CF, Nichols DL, et al. Associations of body fat distribution, circulating sex hormones, and bone density in postmenopausal women. J Clin Endocrinol Metab 1995;80: 1591-6.
23. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis: a comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl JMed 1991:325:1189-95.
24. Castelo-Branco C, Pons F, Gonzalez-Merlo J. Bone mineral density in surgically postmenopausal women receiving hormonal replacement therapy as assessed by dual photon absorptiometry. Maturitas 1993;16:133-7.
25. Field CS, Dry SJ, Wahner HW, et al. Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial. Am J Obstet Gynecol 1993:168:114-21.
26. Ryde SJ, Bowen-Simpkins K, Bowen-Simpkins P, et al. The effect of oestradiol implants on regional and total bone mass: a three-year longitudinal study. Clin Endocrinol (Oxf) 1994; 40:33-8.
27. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 1987;106:40-5.
28. Webber CE, Chettle DR, Bowins RJ, et al. Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation. Environ Health Perspect 1995;103: 1150-3.
29. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-95.
30. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988:13:345-57.
31. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140: 256-61.
32. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-32.
33. Henderson VW, Paganini-Hill A, Emanuel CK, et al. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neural 1994;51:896-900.
34. Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy-effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993;14:283-93.
35. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;! 15:455-6.
36. Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 1995;142:788-95.
37. Stanford JL, Weiss NS, Voigt LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995;274: 137-42.
38. Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985-90.
39. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995:332:1589-93.
40. Rodriguez C, Calle EE, Coates RJ, et al. Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol 1995;141: 828-35.
41. Burton BT, Foster WR, Hirsch J, et al. Health implications of obesity: an NIH consensus development conference. Int J Obes 1985:9:155-70.
42. Metropolitan Life Insurance Company. 1983 Metropolitan height and weight tables. Stat Bull Metrop Life Found 1983; 64:3-9.
43. Rosenberg L, Shapiro S, Kaufman DW, et al. Patterns and determinants of conjugated estrogen use. Am J Epidemiol 1979:109:676-86.
44. Hemminki E, Brambilla DJ, McKinlay SM, et al. Use of estrogens among middle-aged Massachusetts women. DICP 1991;25:418-23.
45. Derby ÇA, Hume AL, Barbour MM, et al. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 1993:137:1125-35.
46. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991:325:756-62.
47. Egeland GM, Matthews KA, Kuller LH, et al. Characteristics of noncontraceptive hormone users. Prev Med 1988;17: 403-11.
48. Cauley JA, Cummings SR, Black DM, et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990:163:1438-44.
49. Griffiths F, Convery B. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy. Br J Gen Pract 1995;45: 355-8.
50. Salamone LM, Pressman AR, Seeley DG, et al. Estrogen replacement therapy: a survey of older women's attitudes. Arch Intern Med 1996;156:1293-7.
51. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol 1993; 46:211-19.
52. Medical Research Council's General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. BMJ 1996;312:473-8.
53. Nachtigall LE. Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol 1990; 75(suppl):77S-80S.
54. Berman RS, Epstein RS, Lydick EG. Compliance of women in taking estrogen replacement therapy. J Women's Health 1996; 5:213-20.
55. Ravnikar VA. Compliance with hormone therapy. Am J Obstet Gynecol 1987; 156:1332-4.
56. Ryan PJ, Harrison R, Blake GM, et al. Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol 1992;99: 325-8.
57. Hammond CB. Women's concerns with hormone replacement therapy-compliance issues. Fertil Steril 1994;62(suppl): 157S-60S.
58. Coope J, Marsh J. Can we improve compliance with long-term HRT? Maturitas 1992;15:151-8.
59. Hahn RG. Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet Gynecol 1989;161:1854-8.
60. den Tonkelaar I, Seidell JC, van Noord PA. Obesity and fat distribution in relation to hot flashes in Dutch women from the DOM project. Maturitas 1996;23:301-5.
61. Anderson E, Hamburger S, Liu JH, et al. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol 1987;156:428-33.
62. Schwing! PJ, Hulka BS, Harlow SD. Risk factors for menopausal hot flashes. Obstet Gynecol 1994;84:29-34.